LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $596,000 | +57.3% | 4,544 | +82.6% | 0.05% | +68.8% |
Q1 2021 | $379,000 | -81.4% | 2,488 | -86.1% | 0.03% | -59.5% |
Q2 2019 | $2,042,000 | -7.1% | 17,892 | +10.4% | 0.08% | -30.1% |
Q4 2018 | $2,198,000 | +36.1% | 16,200 | +107.7% | 0.11% | +242.4% |
Q2 2018 | $1,615,000 | -73.8% | 7,800 | -79.1% | 0.03% | -69.2% |
Q1 2018 | $6,160,000 | +118.4% | 37,300 | +81.1% | 0.11% | +154.8% |
Q4 2017 | $2,820,000 | -19.7% | 20,600 | -20.2% | 0.04% | +5.0% |
Q3 2017 | $3,512,000 | -36.0% | 25,800 | -42.9% | 0.04% | -51.8% |
Q2 2017 | $5,487,000 | +144.7% | 45,200 | +140.4% | 0.08% | -21.0% |
Q2 2016 | $2,242,000 | +37.8% | 18,800 | +23.7% | 0.10% | +32.9% |
Q1 2016 | $1,627,000 | +257.6% | 15,200 | +261.9% | 0.08% | +182.1% |
Q4 2015 | $455,000 | -63.1% | 4,200 | -70.8% | 0.03% | -69.9% |
Q3 2015 | $1,233,000 | +166.9% | 14,400 | +140.0% | 0.09% | +111.4% |
Q1 2015 | $462,000 | – | 6,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |